FDA Inspection 1267356 — Catalent Greenville Inc

Catalent Greenville Inc — FEI 3000209735

The FDA completed an inspection of Catalent Greenville Inc on October 24, 2025 in Greenville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 24, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Greenville, NC (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
188521 CFR 211.165(b)Microbiological testing
191221 CFR 211.166(a)Written program not followed